| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.001 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |